General Description
Cyclacillin is a semisynthetic aminopenicillin antibiotic with a broader spectrum than penicillin but less potent than ampicillin. The drug is unique among penicillins for its rapid oral absorption and high urinary recovery.
Mechanism of Action
Cyclacillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking. This leads to osmotic lysis of susceptible bacteria. The drug is acid-stable and rapidly absorbed, achieving high serum levels. However, it is less active than ampicillin against Haemophilus influenzae and certain E. coli strains, and it is hydrolyzed by beta-lactamases.
Application
Cyclacillin was indicated for respiratory tract infections (otitis media, pharyngitis, sinusitis), urinary tract infections, and skin/soft tissue infections caused by susceptible organisms.